Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
FRTX was delisted on the 18th of December, 2023.
70 hedge funds and large institutions have $35.7M invested in Fresh Tracks Therapeutics, Inc. Common Stock in 2014 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 13 increasing their positions, 21 reducing their positions, and 22 closing their positions.
313% more call options, than puts
Call options by funds: $285K | Put options by funds: $69K
10% less funds holding
Funds holding: 78 → 70 (-8)
14% less capital invested
Capital invested by funds: $41.7M → $35.7M (-$6.05M)
36% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 22
38% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 21
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$2.5M |
| 2 |
SGAM
Smith Group Asset Management
Dallas,
Texas
|
+$628K |
| 3 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$388K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$297K |
| 5 |
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
|
+$260K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$2.26M |
| 2 |
State Street
Boston,
Massachusetts
|
-$1.33M |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$1.02M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$658K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$632K |
FRTX Hedge Fund Activity: Q2 2014 in Review
70 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) for Q2 2014, worth a combined $35.7M — down 14% from $41.7M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of FRTX and 14 opened new positions — a net loss of 8 holders — while 21 trimmed existing stakes and 13 added.
The largest buyer was Great Point Partners, opening a new position worth an estimated $2.5M. The largest seller was BlackRock Fund Advisors, cutting an estimated $2.26M.
- 70 institutional investors held Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) as of Q2 2014, down from 78 in Q1 2014.
- Funds reported $35.7M of Fresh Tracks Therapeutics, Inc. Common Stock stock for Q2 2014, down 14% quarter-over-quarter.
- 14 funds opened new Fresh Tracks Therapeutics, Inc. Common Stock positions in Q2 2014 and 22 closed out, a net change of -8 holders.
- The largest Fresh Tracks Therapeutics, Inc. Common Stock buyer in Q2 2014 was Great Point Partners, an estimated $2.5M added.
- The largest Fresh Tracks Therapeutics, Inc. Common Stock seller in Q2 2014 was BlackRock Fund Advisors, an estimated $2.26M sold.
Based on aggregated 13F filings for Q2 2014.